Riskpilot← Back to searchSign inGet full accessHUSBY OPTIKK LEVANGER AS
ASActiveOrg 919085231Moafjæra 8C, 7606 LevangerRetail sale of medical and orthopaedic goods · NACE 4774Est. 20176 employees
Revenue 2024
NOK 5,1M
+22% vs 2023
EBITDA margin
6.0%
+44% vs 2023
Equity ratio
50.4%
Financial strength
Net profit 2024
NOK 201K
+79% vs 2023
| Revenue | NOK 5,1M | +22% |
| EBITDA | NOK 309K | +44% |
| Net profit | NOK 201K | +79% |
| Total assets | NOK 1,9M | +15% |
| Equity | NOK 975K | -9% |
| Employees | 6 | — |
Legal name
HUSBY OPTIKK LEVANGER AS
Org number
919085231
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
6. juni 2017
Share capital
NOK 500 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Synsundersøkelser med tilhørende salg av optiske artikler, samt annen virksomhet som naturlig står i forbindelse med dette.
Address
Moafjæra 8C, 7606 Levanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1 293 | 3 582 | 3 291 | 3 496 | 3 332 | 3 961 | 4 204 | 5 118 |
| Staff expenses | −425 | −1 161 | −889 | −1 066 | −927 | −1 329 | −1 496 | −1 878 |
| EBITDA | −22 | 294 | 150 | 237 | −84 | 299 | 215 | 309 |
| Depreciation & amort. | −54 | −171 | −171 | −171 | −171 | −145 | −86 | −73 |
| EBIT | −76 | 123 | −21 | 66 | −255 | 154 | 129 | 236 |
| Net financials | −7 | −20 | −8 | −1 | −3 | −2 | 17 | 18 |
| Profit before tax | −82 | 103 | −29 | 65 | −258 | 152 | 147 | 254 |
| Tax | −19 | 24 | −6 | 14 | −57 | 33 | 34 | 53 |
| Net profit | −64 | 80 | −23 | 51 | −201 | 119 | 113 | 201 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 2 214 | 2 321 | 2 263 | 2 335 | 2 163 | 1 988 | 1 678 | 1 934 |
| Equity | 436 | 516 | 493 | 544 | 343 | 961 | 1 074 | 975 |
| Long-term debt | 1 500 | 1 505 | 1 500 | 1 508 | 1 500 | 500 | 0 | 0 |
| Short-term debt | 278 | 300 | 270 | 283 | 320 | 527 | 604 | 959 |
| Total debt | 1 778 | 1 805 | 1 770 | 1 791 | 1 820 | 1 027 | 604 | 959 |
EBITDA margin
6.0%
This company
15.8%
Market median
-62% vs market
20172024
Equity ratio
50.4%
This company
38.2%
Market median
+32% vs market
20172024
Return on equity
20.6%
This company
18.4%
Market median
+12% vs market
20172024
Net profit margin
3.9%
This company
8.1%
Market median
-52% vs market
20172024
Asset turnover
2.65×
This company
1.12×
Market median
+137% vs market
20172024
Debt / equity
0.98×
This company
0.62×
Market median
+58% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-05-18 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HF Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
TH Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
CK Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2022 | |
Optotrade As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Optoteam Holding As
HUSBY OPTIKK LEVANGER AS Board members of HUSBY OPTIKK LEVANGER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henning Franz Friedrich | Chief Executive Officer | 0 companies |
| Terje Husby | Chief Executive Officer | 0 companies |
| Christina Kolsvik Fagerkind | Chief Executive Officer | 0 companies |
| Grethe Elianna Friedrich | Chairman | 0 companies |
| Anne Sofie Staven Husby | Board of Directors | 0 companies |
| Thanh Tran | Chairman | 0 companies |
| Arne Johan Halvorsen | Board of Directors | 0 companies |